The Role of Anxiolytics in Hypertensive Urgency Management

Frane Paštrović1, Petar Krešimir Okštajner, Marko Vodanović

  • 1Institute for Emergency Medicine of Zagreb County, Zagreb, Croatia.

Psychiatria Danubina
|November 19, 2020
PubMed

Insights

Anxiolytic therapy may help manage hypertensive urgency outside hospitals. Patients receiving anxiolytics showed a significant reduction in systolic blood pressure compared to those who did not.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Pharmacology

Background:

  • Current medical guidelines lack specific recommendations for managing hypertensive urgency in out-of-hospital settings.
  • Hypertensive urgency, characterized by severely elevated blood pressure without acute target organ damage, requires effective management strategies.

Purpose of the Study:

  • To investigate the efficacy of anxiolytic therapy as a treatment for hypertensive urgency in an out-of-hospital environment.
  • To determine if anxiolytic administration contributes to a greater reduction in systolic blood pressure (SBP) during hypertensive urgency events.

Main Methods:

  • Retrospective analysis of data collected over one year from an out-of-hospital unit.
  • Inclusion criteria focused on patients diagnosed with arterial hypertension, specifically those experiencing hypertensive urgency.
  • Comparison of SBP reduction between patients who received anxiolytic therapy and those who did not.

Main Results:

  • Arterial hypertension was diagnosed in 178 patients, with 144 meeting criteria for hypertensive urgency.
  • Patients receiving anxiolytic therapy demonstrated a statistically significant greater reduction in SBP (p=0.03) compared to the control group.
  • The mean SBP reduction in the anxiolytic group was 19.5±7.2%, versus 10.1±6.9% in the control group.

Conclusions:

  • Anxiolytic therapy shows potential as a valuable component in the out-of-hospital management of hypertensive urgency.
  • The findings suggest that addressing anxiety may play a role in effectively lowering blood pressure during hypertensive crises.

Related Concept Videos

Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
812
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.8K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.9K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.1K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.2K